drugset / Trial / NCT00243984
Efficacy of Topiramate for Weight Loss in Subjects With Metabolic Syndrome
Phase 3
Suspended
90 enrolled
Northeastern Ohio Universities College of Medicine
Aultman Health Foundation · collabCleveland Clinic Akron General · collabForum Health · collabMercy Medical Center · collabSt. Elizabeth Health Center · collab
RandomizedSingle-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy of topiramate compared to placebo in the treatment of obesity in metabolic syndrome. Secondary objectives include topiramate and weight loss effects on lipid levels, HbA1C, insulin resistance, and blood pressure.
Timeline
- Start
- 2005-03
- Primary completion
- —
- Completion
- 2007-11
Outcome
Outcome not reported
Stopped: “Study was discontinued because of high drop out rate.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Topiramate | Small molecule | — | — |